Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pioneer Services Inc OTC>BB PSVC -- Ignore unavailable to you. Want to Upgrade?

To: vcap who wrote (101)	6/2/1998 2:21:00 PM
From: Bob Sokol	Read Replies (1) \| Respond to of 140

University of Oklahoma Health Sciences Center Approves Study of Jacobson Resonance in Epilepsy BusinessWire, Tuesday, June 02, 1998 at 11:53 BOCA RATON, Fla.--(BUSINESS WIRE)--June 2, 1998--Pioneer Services International Ltd. (OTC BB:PSVC) has received notification that approval has been granted by the University of Oklahoma Health Sciences Center's Institutional Review Board to commence with a double blind, randomized clinical study utilizing Jacobson Resonance Technology in Epilepsy. More specifically, the study will examine the feasibility of employing low frequency picotesla range magnetic fields to possibly reduce seizure frequency of epilepsy patients. According to Associate Professor K.J. Oommen, Department of Neurology and Director of The Comprehensive Oklahoma Program on Epilepsy and principal investigator of the clinical study, "Screening of potential study subjects has already begun." Co-investigator and a member of Pioneer's Scientific Advisory Board, Professor William Yamanashi stated, "In accordance with clear correlations of theory to experiment as published in Neurological Research, co-authored by Dr. Jerry Jacobson and myself, there is hope and reasonable expectation that we will demonstrate a reduction in seizure frequency of epileptic patients, similar to the research study conclusions arrived at by Professors Anninos and Tsagas in Greece. "This study will be the first double blind clinical examination of the potential efficacy of picotesla range magnetic fields in the treatment of epilepsy. Picotesla fields are the same kind of magnetic fields that exist in the brain and heart, and are much weaker than the earth's magnetic field." Dr. Jerry Jacobson, Chairman of Pioneer Services added, "We may extrapolate from preliminary data derived from in-vitro studies on nerve growth and repair accomplished at Cornell University Medical College, double blind randomized chronic pain studies performed at The National Medical and Research Institute, as well as the reported successful treatment of several hundred neurological patients with picotesla range magnetic fields in Greece and America. Resonance technology, in my opinion, does indeed provide real hope that a non-invasive, painless and safe modality may one day prove to be a viable treatment method to combat neurological disorders." Pioneer Services International Ltd. is positioned to be an innovator and leader in the field of Bio-medical and Bio-electromagnetic technology. This release contains forward-looking statements that are subject to risks and uncertainties, including but not limited to, certain delays beyond the company's control with respect to business, events, regulatory approvals, and other risks which are detailed from time to time in the company's filings with the Securities and Exchange Commission.